The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Molecular modeling in drug discovery
Open accessAbstract
With the financial requirements and high time associated with bringing a commercial drug to the market, the application of computer-aided drug design has been recognized as a powerful technology in the drug discovery pipeline. In accelerating drug discovery, molecular modeling techniques have experienced considerable growth in computational capabilities over the last decade. Pharmaceutical companies and academic research organizations are currently using various computational modeling techniques to lower the cost and time required for the discovery of an effective drug. In this article, we focus on reviewing three key components of molecular modeling (Molecular Docking, Molecular Dynamics, and ADMET modeling), their applications, and limitations in small-molecule drug discovery. We discussed the technicalities encircling molecular dynamics and docking, the algorithms used to develop the docking softwares, and the models explored by these algorithms coupled with their scoring functions. We also reviewed the influence of molecular dynamics simulations (all atoms and coarse-grained molecular dynamics simulations) in drug discovery and also elucidated how the ensembles generated from MD simulations could pave the way for novel drug discovery. Furthermore, we briefly explain the role played by pharmacokinetics and pharmacodynamics profiling in discovering new leads for therapeutic efficacy. Besides the computational success of molecular modeling in drug discovery, we highlighted the experimental corroboration of in silico discovered drug candidates. However, as there is hardly a drug in the market discovered primarily with the use of computational modeling, we concluded the review by proposing possible solutions that could foster the advancement and clinical success of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006) · Bioinformatics · doi:10.1093/bioinformatics/bti770 · Cited by 6,988
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
I-TASSER: a unified platform for automated protein structure and function prediction
Roy, A., Kucukural, A., & Zhang, Y. (2010) · Nature Protocols · doi:10.1038/nprot.2010.5 · Cited by 6,170
Research works printed but not linked: 18
- Ferrè, 2004, SURFACE: a database of protein surface regions for functional annotation, Nucleic Acids Res, 32, D240, 10.1093/nar/gkh054 · doi:10.1093/nar/gkh054
- Chikhi, 2010, Real-time ligand binding pocket database search using local surface descriptors, Proteins, 78, 2007, 10.1002/prot.22715 · doi:10.1002/prot.22715
- Pereira, 2004, Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid, Acta Crystallogr D Biol Crystallogr, 60, 2310, 10.1107/S090744490402517X · doi:10.1107/s090744490402517x
- Yang, 2000, Flexible ligand docking using a robust evolutionary algorithm, J Comput Chem, 21, 988, 10.1002/1096-987X(200008)21:11<988::AID-JCC8>3.0.CO;2-H · doi:10.1002/1096-987x(200008)21:11<988::aid-jcc8>3.0.co;2-h
- Taylor, 2002, A review of protein-small molecule docking methods, J Comput Aided Mol Des, 16, 151, 10.1023/A:1020155510718 · DOI · Paper page
- Briand, 2019, Combined ensemble docking and machine learning in identification of therapeutic agents with potential inhibitory effect on human CES1, Molecules, 24, 2747, 10.3390/molecules24152747 · doi:10.3390/molecules24152747
- Kandeel, 2018, Molecular dynamics and binding selectivity of nucleotides and polynucleotide substrates with EIF2C2/Ago2 PAZ domain, Int J Biol Macromol, 107, 2566, 10.1016/j.ijbiomac.2017.10.145 · doi:10.1016/j.ijbiomac.2017.10.145
- Peng, 2015, Insilico approaches in anesthetic drug development: computer aided drug designing, Drug Res, 65, 587
- Bao, 2018, Discover potential inhibitors for PFKFB3 using 3D-QSAR, virtual screening, molecular docking and molecular dynamics simulation, J Recept Signal Transduct Res, 38, 413, 10.1080/10799893.2018.1564150 · doi:10.1080/10799893.2018.1564150
- Toyoda, 1999, Development of MD engine: high-speed accelerator with parallel processor design for molecular dynamics simulations, J Comput Chem, 20, 10.1002/(SICI)1096-987X(19990130)20:2<185::AID-JCC1>3.0.CO;2-L · doi:10.1002/(sici)1096-987x(19990130)20:2<185::aid-jcc1>3.0.co;2-l
- de Oliveira, 2006, On the application of accelerated molecular dynamics to liquid water simulations, J Phys Chem B, 110, 22695, 10.1021/jp062845o · doi:10.1021/jp062845o
- Chen, 2009, Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase, J Med Chem, 52, 2716, 10.1021/jm8011905 · doi:10.1021/jm8011905
- Adelusi, 2021, Molecular docking assessment of clinically approved antiviral drugs against Mpro, spike glycoprotein and angiotensin converting enzyme-2 revealed probable anti-SARS-CoV-2 potential, Trop J Nat Prod Res, 5
- Sandhaus, 2018, Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays, Sci Rep, 8, 1437, 10.1038/s41598-018-19944-4 · doi:10.1038/s41598-018-19944-4
- Peiffer, 2021, TMPRSS2 inhibitor discovery facilitated through an in silico and biochemical screening platform, bioRxiv [Preprint]
- Theerawatanasirikul, 2020, Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses, Antivir Res, 182, 10.1016/j.antiviral.2020.104927 · doi:10.1016/j.antiviral.2020.104927
- Kaproń, 2019, Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies, Eur J Pharmaceut Sci, 129, 42, 10.1016/j.ejps.2018.12.018 · doi:10.1016/j.ejps.2018.12.018
- Singla, 2019, Stevia rebaudiana targeting α-amylase: an in-vitro and in-silico mechanistic study, Nat Prod Res, 33, 548, 10.1080/14786419.2017.1395433 · doi:10.1080/14786419.2017.1395433
Cited by
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Baselious, F., Robaa, D., & Sippl, W. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107700 · Cited by 20
Metadata
- Authors
- Adelusi, T. I., Oyedele, A.-Q. K., Boyenle, I. D., Ogunlana, A. T., Adeyemi, R. O., Ukachi, C. D., Idris, M. O., Olaoba, O. T., Adedotun, I. O., Kolawole, O. E., Xiaoxing, Y., & Abdul-Hammed, M.
- Venue
- Informatics in Medicine Unlocked
- Publisher
- Elsevier BV
- Published
- 2022
- Volume
- 29
- Pages
- 100880
- ISSN
- 2352-9148 (ISSN-L)
- OpenAlex
- W4211216582
- Cited by
- 387
- References
- 207
- FWCI
- 39.40
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 40 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular modeling in drug discovery. https://app.cochat.ai/papers/10.1016/j.imu.2022.100880
- The paper
- Adelusi, T. I., Oyedele, A.-Q. K., Boyenle, I. D., Ogunlana, A. T., Adeyemi, R. O., Ukachi, C. D., Idris, M. O., Olaoba, O. T., Adedotun, I. O., Kolawole, O. E., Xiaoxing, Y., & Abdul-Hammed, M. (2022). Molecular modeling in drug discovery. Informatics in Medicine Unlocked. https://doi.org/10.1016/j.imu.2022.100880
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.